Skip to main content
2025 CRT Conference Main banner
Back

Kamran Muhammad, MD

Director, Structural Heart Disease Program; Co-director Cardiac Catheterization Laboratory
Oklahoma Heart Institute at Hillcrest Medical Center
Tulsa, Oklahoma, United States

Kamran I. Muhammad, M.D., FACC, FSCAI, is a subspecialist in interventional cardiology with Oklahoma Heart Institute (OHI) with expertise in all facets of interventional cardiology including interventional therapies for structural heart disease. Dr. Muhammad currently serves as the physician lead for the cardiovascular service line at Hillcrest HealthCare System, co-director for the cardiac catheterization laboratory at Hillcrest Medical Center and director of the structural heart disease program at Oklahoma Heart Institute. His main interest is in the area of structural heart disease, and he currently serves as the priniple investigator at OHI for multiple trials of transcatheter valve therapies and structural heart therapies for heart failure.

Disclosure(s): Abbott Labs: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Ancora: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Emboline, Inc.: Consultant (Ongoing), Grant/Research Support (Ongoing); Medtronic, Inc.: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Presentation(s):